Novus Acquisition & Development Corp (NDEV)

novusNovus Acquisition & Development Corp. is a service provider that targets the healthcare component of the medical marijuana industry. The company provides health insurance and related insurance solutions within the industry in states where legal cannabis programs exist. They also seek to provide physicians’ education programs, business development services, and pharmaceutical research and development services within the industry.

Many studies and researches show that medical marijuana is effective in treating a wide variety of medical conditions. In addition, a number of pharmaceutical companies and research companies are conducting extensive studies for the potential use of marijuana in treating major medical conditions such as Crohn’s disease, childhood epilepsy, and certain types of cancer.

Most insurance companies work with federal programs such as Medicaid and Medicare. This means that these insurance providers are required to adhere to all federal laws, including the laws that classify marijuana as a Schedule I Controlled Substance. As a result, patients using medical marijuana to treat serious medical conditions lack insurance coverage even when the treatment is legal on a state level.

Novus Medical Group, Inc., a subsidiary of Novus Acquisition & Development Corp., fills a vital part in the legal cannabis and hemp marketplace in the United States by establishing cost savings plans developed for patients treated with cannabis and hemp.  Even if patients have health insurance, the program helps them save money on services and products not usually covered by insurance.

Novus Acquisition & Development Corp., a part of the MMJ Index, is traded in the OTC market under the stock symbol NDEV. Novus is comprised of Wall Street veterans who have focused the company’s business model on the healthcare sector of the medical marijuana industry.

Since marijuana is not federally approved, Novus Acquisition & Development Corp. does not and will not cultivate, grow, extract, handle, transport, supply, and dispense cannabis or any substances that violate the Controlled Substance Act or the United States law. The company will continue to adhere to state and federal laws.


[hungryfeed max_items=”5″ template=”1″ url=”feed://feeds.finance.yahoo.com/rss/2.0/headline?s=NDEV&region=US&lang=en-US”]